search
Back to results

A Study of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS

Primary Purpose

Cytomegalovirus Retinitis, HIV Infections

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Cidofovir
Sponsored by
Gilead Sciences
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cytomegalovirus Retinitis

Eligibility Criteria

13 Years - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Information not available

Sites / Locations

    Outcomes

    Primary Outcome Measures

    Secondary Outcome Measures

    Full Information

    First Posted
    November 2, 1999
    Last Updated
    June 23, 2005
    Sponsor
    Gilead Sciences
    Collaborators
    Anderson Clinical Research
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT00002384
    Brief Title
    A Study of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS
    Official Title
    Vistide (Cidofovir Intravenous) Treatment IND Protocol for Relapsing Cytomegalovirus Retinitis in Patients With AIDS
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    August 1997
    Overall Recruitment Status
    Unknown status
    Study Start Date
    undefined (undefined)
    Primary Completion Date
    undefined (undefined)
    Study Completion Date
    undefined (undefined)

    3. Sponsor/Collaborators

    Name of the Sponsor
    Gilead Sciences
    Collaborators
    Anderson Clinical Research

    4. Oversight

    5. Study Description

    Brief Summary
    Incomplete Closed Protocol

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Cytomegalovirus Retinitis, HIV Infections

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable

    8. Arms, Groups, and Interventions

    Intervention Type
    Drug
    Intervention Name(s)
    Cidofovir

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    13 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Information not available

    12. IPD Sharing Statement

    Citations:
    Citation
    Stagg RJ, Gathe J, Lieberman RM, Nuessle SJ, Davis JL, Ruane P, Bellman PC, Horgan M, Jaffe HS. The Vistide (cidofovir injection) treatment IND for relapsing CMV retinitis (CMV-R). Conf Retroviruses Opportunistic Infect. 1997 Jan 22-26;4th:120 (abstract no 306)
    Results Reference
    background

    Learn more about this trial

    A Study of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS

    We'll reach out to this number within 24 hrs